Englewood, Colorado, United States In 1999 was created Consolidated Investment Group, which is appeared as VC. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Englewood.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Consolidated Investment Group, startups are often financed by Maayan Ventures, Docor International Management, iVentures Asia Ltd. The meaningful sponsors for the fund in investment in the same round are iVentures Asia Ltd, Docor International Management, iNetworks 360. In the next rounds fund is usually obtained by iVentures Asia Ltd, Docor International Management, Toro Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Nanotechnology, Biotechnology. Among the various public portfolio startups of the fund, we may underline SP Nano, Gizmox
The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2015.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Axan Invest | - |
| Gengyu Touzi | Beijing, Beijing, China |
| Guodu Securities | - |
| Highlands Ventures | Boulder, Colorado, United States |
| Miyagin Venture Capital | Japan, Miyazaki, Miyazaki Prefecture |
| Naadam | New York, New York, United States |
| Sagard | France, Ile-de-France, Paris |
| Sharpstone Capital | France, Ile-de-France, Paris |
| VERSO Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ZetaGen Therapeutics | $9M | 11 Aug 2023 | Syracuse, New York, United States | ||
SP Nano | $2M | 20 Jun 2014 | North District | ||
Gizmox | $7M | 23 Apr 2013 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ZetaGen Therapeutics | $9M | 11 Aug 2023 | Syracuse, New York, United States | ||
SP Nano | $2M | 20 Jun 2014 | North District | ||
Gizmox | $7M | 23 Apr 2013 | Cambridge, Massachusetts, United States |
